Developing a vaccine using Vero cells for respiratory syncytial virus (RSV).
Task V08: Process Development for Scale-up of Vero Cells on Micro-Carriers for Manufacturing of a Live-Attenuated RSV Vaccine
This study is working on creating a new vaccine to help protect against respiratory syncytial virus (RSV) by improving how it's made, so it can be safely tested in people.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Idt Biologika Gmbh NIH-funded |
| Lab location | 1 site (Dessau-Rosslau, Germany) |
| Project ID | NIH-10002373 on NIH RePORTER |
What this research studies
This research focuses on the development and manufacturing processes for a live-attenuated vaccine against respiratory syncytial virus (RSV) using Vero cells grown on micro-carriers. The project involves optimizing the production methods to ensure compliance with good manufacturing practices (cGMP) for clinical trials. By utilizing advanced techniques and regulatory support, the research aims to facilitate the introduction of effective vaccines against RSV and other infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include infants and young children who are at high risk for severe RSV infections.
Not a fit: Patients who are not at risk for RSV or those who have already been vaccinated against it may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a safe and effective vaccine for RSV, potentially reducing the incidence of this common respiratory infection.
How similar studies have performed: Other research has shown success in developing vaccines using similar methodologies, indicating a promising approach for this project.
Where this research is happening
Dessau-Rosslau, Germany
- Idt Biologika Gmbh — Dessau-Rosslau, Germany (Active)
Researchers
- Principal investigator: Cristina, Arbelo — Idt Biologika Gmbh
- Study coordinator: Cristina, Arbelo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.